申请人:Akzona Incorporated
公开号:US04039558A1
公开(公告)日:1977-08-02
The invention is dealing with compounds of the general formula: ##STR1## as well as the pharmaceutically acceptable salts thereof, in which X represents oxygen, sulphur, the group >NR.sub.7 or the group --CR.sub.8 R.sub.9 --, R.sub.1, r.sub.2, r.sub.3 and R.sub.4 represent hydrogen, hydroxy, halogen, an alkyl, alkoxy or alkylthio group or a trifluoromethyl group, R.sub.5 and R.sub.6 represent hydrogen, an alkyl group or an aralkyl group, R.sub.7 represents hydrogen or alkyl (1-4 C), R.sub.8, r.sub.9 represent hydrogen or methyl, and Q represents hydrogen (2H) or oxygen, Having valuable antihistamine, sedative and antidepressive properties.
该发明涉及一般式为:##STR1##的化合物及其药学上可接受的盐,其中X代表氧、硫、>NR.sub.7基团或--CR.sub.8 R.sub.9--基团,R.sub.1、r.sub.2、r.sub.3和R.sub.4代表氢、羟基、卤素、烷基、烷氧基或烷硫基或三氟甲基基团,R.sub.5和R.sub.6代表氢、烷基或芳基烷基,R.sub.7代表氢或烷基(1-4 C),R.sub.8、r.sub.9代表氢或甲基,Q代表氢(2H)或氧,具有有价值的抗组胺、镇静和抗抑郁特性。